Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Howe

Showing results (561-570 of 656) with videos related to

Pageof 66
Sort By:
American Journal of Epidemiology|December 1, 1985
Dietary factors and the incidence of cancer of the stomachH A Risch, M Jain, N W Choi, et al.
Spine|December 17, 2019
Hospital and Surgeon Variation in Patient-reported Functional Outcomes After Lumbar Spine Fusion: A Statewide EvaluationSara Khor, Danielle C Lavallee, Amy M Cizik, et al.
Annals of Surgical Oncology|October 13, 2022
Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysisIoannis A Ziogas, Panagiotis T Tasoudis, Luis C Borbon, et al.
American Journal of Epidemiology|April 15, 1995
Family history and prostate cancer risk in black, white, and Asian men in the United States and CanadaA S Whittemore, A H Wu, L N Kolonel, et al.
Surgery|November 20, 2016
Comparative analysis of radioactive iodine versus thyroidectomy for definitive treatment of Graves diseaseVincent T Wu, Allison W Lorenzen, Anna C Beck, et al.
Annals of Surgical Oncology|July 14, 2020
It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine TumorsCatherine G Tran, Scott K Sherman, Aaron T Scott, et al.
Annals of Surgical Oncology|July 8, 2022
Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?Luis C Borbon, Catherine G Tran, Scott K Sherman, et al.
Human Molecular Genetics|July 1, 1993
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCH Donis-Keller, S Dou, D Chi, et al.
Cancer Causes & Control : CCC|February 19, 2000
Premorbid diet in relation to survival from prostate cancer (Canada)D J Kim, R P Gallagher, T G Hislop, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoidPowel H Brown, Kotha Subbaramaiah, Amoi P Salmon, et al.
Pageof 66

Showing results (561-570 of 656) with videos related to

Sort By:
Pageof 66
American Journal of Epidemiology|December 1, 1985
Dietary factors and the incidence of cancer of the stomachH A Risch, M Jain, N W Choi, et al.
Spine|December 17, 2019
Hospital and Surgeon Variation in Patient-reported Functional Outcomes After Lumbar Spine Fusion: A Statewide EvaluationSara Khor, Danielle C Lavallee, Amy M Cizik, et al.
Annals of Surgical Oncology|October 13, 2022
Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysisIoannis A Ziogas, Panagiotis T Tasoudis, Luis C Borbon, et al.
American Journal of Epidemiology|April 15, 1995
Family history and prostate cancer risk in black, white, and Asian men in the United States and CanadaA S Whittemore, A H Wu, L N Kolonel, et al.
Surgery|November 20, 2016
Comparative analysis of radioactive iodine versus thyroidectomy for definitive treatment of Graves diseaseVincent T Wu, Allison W Lorenzen, Anna C Beck, et al.
Annals of Surgical Oncology|July 14, 2020
It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine TumorsCatherine G Tran, Scott K Sherman, Aaron T Scott, et al.
Annals of Surgical Oncology|July 8, 2022
Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?Luis C Borbon, Catherine G Tran, Scott K Sherman, et al.
Human Molecular Genetics|July 1, 1993
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCH Donis-Keller, S Dou, D Chi, et al.
Cancer Causes & Control : CCC|February 19, 2000
Premorbid diet in relation to survival from prostate cancer (Canada)D J Kim, R P Gallagher, T G Hislop, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoidPowel H Brown, Kotha Subbaramaiah, Amoi P Salmon, et al.
Pageof 66